The expression of FAS-associated factor 1 and heat shock protein 70 in ovarian cancer

키워드

참고문헌 (39)

1. American Cancer Society, "Cancer facts & figures" (2010), American Cancer Society
2. National Cancer Control Institute, "2008 National cancer statistics", National Cancer Center, ~ (2010)
3. Ren J, "Tumor markers for early detection of ovarian cancer", Expert Rev Mol Diagn, 10, pp.787~798 (2010)
4. Kabawat SE, "Tissue distribution of a coelomic-epitheliumrelated antigen recognized by the monoclonal antibody OC125", Int J Gynecol Pathol, 2, pp.275~285 (1983)
5. Jacobs I, "The CA 125 tumour-associated antigen:a review of the literature", Hum Reprod, 4, pp.1~12 (1989)
6. Berek JS, "Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection", Cancer, 76(10 Suppl), pp.2092~2096 (1995)
7. Gadducci A, "The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis", Gynecol Oncol, 44, pp.147~154 (1992)
8. Anderson GL, "Ovarian cancer biomarker screening:still too early to tell", Womens Health (Lond Engl), 6, pp.487~490 (2010)
9. Yu JW, "FLIP and the death effector domain family", Oncogene, 27, pp.6216~6227 (2008)
10. Chu K, "A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis", Proc Natl Acad Sci U S A, 92, pp.11894~11898 (1995)
11. Ryu SW, "Apoptosis induced by human Fas-associated factor 1, hFAF1, requires its ubiquitin homologous domain, but not the Fas-binding domain", Biochem Biophys Res Commun, 286, pp.1027~1032 (2001)
12. Menges CW, "FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis", Cell Cycle, 8, pp.2528~2534 (2009)
13. Bjorling-Poulsen M, "The pro-apoptotic FAS-associated factor 1 is specifically reduced in human gastric carcinomas", Int J Oncol, 23, pp.1015~1023 (2003)
14. Hartl FU, "Molecular chaperones in cellular protein folding", Nature, 381, pp.571~579 (1996)
15. Bukau B, "The Hsp70 and Hsp60 chaperone machines", Cell, 92, pp.351~366 (1998)
16. Chuma M, "Expression profiling in multistage hepatocarcinogenesis:identification of HSP70 as a molecular marker of early hepatocellular carcinoma", Hepatology, 37, pp.198~207 (2003)
17. Kim HJ, "Human Fasassociated factor 1 interacts with heat shock protein 70and negatively regulates chaperone activity", J Biol Chem, 280, pp.8125~8133 (2005)
18. Bea S, "Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling", Blood, 113, pp.3059~3069 (2009)
19. Weersma RK, "Confirmation of multiple Crohn’s disease susceptibility loci in a large Dutch-Belgian cohort", Am J Gastroenterol, 104, pp.630~638 (2009)
20. Hidalgo A, "Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma", BMC Cancer, 5, pp.77~ (2005)
21. Suto R, "A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides", Science, 269, pp.1585~1588 (1995)
22. Asea A, "HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine", Nat Med, 6, pp.435~442 (2000)
23. Jaattela M, "Overexpression of major heat shock protein hsp70 inhibits tumor necrosis factor-induced activation of phospholipase A2", J Immunol, 151, pp.4286~4294 (1993)
24. Soti C, "Molecular chaperones in the etiology and therapy of cancer", Pathol Oncol Res, 4, pp.316~321 (1998)
25. Nylandsted J, "Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization", J Exp Med, 200, pp.425~435 (2004)
26. Proskuryakov SY, "Necrosis:a specific form of programmed cell death?", Exp Cell Res, 283, pp.1~16 (2003)
27. Kaur J, "Cell surface expression of 70 kDa heat shock protein in human oral dysplasia and squamous cell carcinoma: correlation with clinicopathological features", Oral Oncol, 34, pp.93~98 (1998)
28. Trieb K, "Reversible downregulation of telomerase activity by hyperthermia in osteosarcoma cells", Int J Hyperthermia, 16, pp.445~448 (2000)
29. Park MY, "Fas-associated factor-1 inhibits nuclear factor-kappaB (NF-kappaB)activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaB", J Biol Chem, 279, pp.2544~2549 (2004)
30. McConkey DJ, "Mechanisms of proteasome inhibitor action and resistance in cancer", Drug Resist Updat, 11, pp.164~179 (2008)
31. Baud V, "Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls", Nat Rev Drug Discov, 8, pp.33~40 (2009)
32. Fan XM, "Inhibition of proteasome function induced apoptosis in gastric cancer", Int J Cancer, 93, pp.481~488 (2001)
33. Birle DC, "Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors", Cancer Res, 67, pp.1735~1743 (2007)
34. Yang DT, "Prevalence of bortezomib-resistant constitutive NFkappaB activity in mantle cell lymphoma", Mol Cancer, 7, pp.40~ (2008)
35. Lazaris AC, "Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified", Breast Cancer Res Treat, 43 (1997)
36. Athanassiadou P, "Expression of p53, bcl-2 and heat shock protein (hsp72) in malignant and benign ovarian tumours", Eur J Cancer Prev, 7, pp.225~231 (1998)
37. Kim KK, "HSP70 and ER expression in cervical intraepithelial neoplasia and cervical cancer", J Korean Med Sci, 13, pp.383~388 (1998)
38. Nanbu K, "Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas", Cancer Detect Prev, 22, pp.549~555 (1998)
39. Bonay M, "Expression of heat shock proteins in human lung and lung cancers", Am J Respir Cell Mol Biol, 10, pp.453~461 (1994)

관련 논문AI추천